LOGC
Bank of America’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1
| Closed | – | – | 7693 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7421 |
|
|
2022
Q2 | $0 | Sell |
1
-861
| -100% | – | ﹤0.01% | 7686 |
|
|
2022
Q1 | $1K | Sell |
862
-3,835
| -82% | -$4.45K | ﹤0.01% | 7349 |
|
|
2021
Q4 | $11K | Sell |
4,697
-2,009
| -30% | -$4.71K | ﹤0.01% | 6814 |
|
|
2021
Q3 | $31K | Sell |
6,706
-3,385
| -34% | -$15.6K | ﹤0.01% | 6355 |
|
|
2021
Q2 | $45K | Sell |
10,091
-20,585
| -67% | -$91.8K | ﹤0.01% | 6075 |
|
|
2021
Q1 | $223K | Buy |
30,676
+17,768
| +138% | +$129K | ﹤0.01% | 5305 |
|
|
2020
Q4 | $99K | Buy |
12,908
+6,057
| +88% | +$46.5K | ﹤0.01% | 5261 |
|
|
2020
Q3 | $62K | Buy |
6,851
+1,711
| +33% | +$15.5K | ﹤0.01% | 5289 |
|
|
2020
Q2 | $43K | Buy |
5,140
+2,351
| +84% | +$19.7K | ﹤0.01% | 5464 |
|
|
2020
Q1 | $14K | Sell |
2,789
-670
| -19% | -$3.36K | ﹤0.01% | 5658 |
|
|
2019
Q4 | $25K | Sell |
3,459
-955
| -22% | -$6.9K | ﹤0.01% | 5614 |
|
|
2019
Q3 | $48K | Buy |
4,414
+520
| +13% | +$5.66K | ﹤0.01% | 5506 |
|
|
2019
Q2 | $51K | Sell |
3,894
-740
| -16% | -$9.69K | ﹤0.01% | 5522 |
|
|
2019
Q1 | $45K | Buy |
4,634
+1,278
| +38% | +$12.4K | ﹤0.01% | 5477 |
|
|
2018
Q4 | $34K | Buy |
+3,356
| New | +$34K | ﹤0.01% | 5581 |
|